Bliss GVS Pharma Limited

NSE BLISSGVS.NS

Bliss GVS Pharma Limited Current Liabilities for the year ending March 31, 2024: USD 19.16 M

Bliss GVS Pharma Limited Current Liabilities is USD 19.16 M for the year ending March 31, 2024, a -18.51% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Bliss GVS Pharma Limited Current Liabilities for the year ending March 31, 2023 was USD 23.51 M, a -23.40% change year over year.
  • Bliss GVS Pharma Limited Current Liabilities for the year ending March 31, 2022 was USD 30.70 M, a 10.38% change year over year.
  • Bliss GVS Pharma Limited Current Liabilities for the year ending March 31, 2021 was USD 27.81 M, a -9.74% change year over year.
  • Bliss GVS Pharma Limited Current Liabilities for the year ending March 31, 2020 was USD 30.81 M, a 3.42% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NSE: BLISSGVS.NS

Bliss GVS Pharma Limited

Description

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Similar companies

SHILPAMED.NS

Shilpa Medicare Limited

USD 8.18

0.56%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 23.91

2.07%

DCAL.NS

Dishman Carbogen Amcis Limited

USD 2.68

1.39%

INDOCO.NS

Indoco Remedies Limited

USD 2.88

1.89%

BALMLAWRIE.NS

Balmer Lawrie & Co. Ltd.

USD 2.27

3.12%

StockViz Staff

February 2, 2025

Any question? Send us an email